BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 33809565)

  • 1. Differentiating Neuroblastoma: A Systematic Review of the Retinoic Acid, Its Derivatives, and Synergistic Interactions.
    Bayeva N; Coll E; Piskareva O
    J Pers Med; 2021 Mar; 11(3):. PubMed ID: 33809565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The vitamin A analogues: 13-cis retinoic acid, 9-cis retinoic acid, and Ro 13-6307 inhibit neuroblastoma tumour growth in vivo.
    Ponthan F; Borgström P; Hassan M; Wassberg E; Redfern CP; Kogner P
    Med Pediatr Oncol; 2001 Jan; 36(1):127-31. PubMed ID: 11464864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of retinoic acid on the in vitro and in vivo growth of neuroblastoma cells.
    Abemayor E
    Laryngoscope; 1992 Oct; 102(10):1133-49. PubMed ID: 1328787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of isomerisation on the growth inhibitory effects and cellular activity of 13-cis and all-trans retinoic acid in neuroblastoma cells.
    Veal GJ; Errington J; Redfern CP; Pearson AD; Boddy AV
    Biochem Pharmacol; 2002 Jan; 63(2):207-15. PubMed ID: 11841795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of 18F-Fluorodeoxyglucose Positron Emission Tomography for Follow-Up of 13-cis-Retinoic Acid Treatment for Residual Neuroblastoma After Myeloablative Chemotherapy.
    Sato Y; Kurosawa H; Sakamoto S; Kuwashima S; Hashimoto T; Okamoto K; Tsuchioka T; Fukushima K; Arisaka O
    Medicine (Baltimore); 2015 Aug; 94(31):e1290. PubMed ID: 26252303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced potency of 9-cis versus all-trans-retinoic acid to induce the differentiation of human neuroblastoma cells.
    Han G; Chang B; Connor MJ; Sidell N
    Differentiation; 1995 Jul; 59(1):61-9. PubMed ID: 7589896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoic acid enhances killing of neuroblastoma cells by Newcastle disease virus.
    Reichard KW; Lorence RM; Katubig BB; Peeples ME; Reyes HM
    J Pediatr Surg; 1993 Oct; 28(10):1221-5; discussion 1225-6. PubMed ID: 8263678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of 13 cis-retinoic acid and tolfenamic acid induces apoptosis and effectively inhibits high-risk neuroblastoma cell proliferation.
    Shelake S; Eslin D; Sutphin RM; Sankpal UT; Wadwani A; Kenyon LE; Tabor-Simecka L; Bowman WP; Vishwanatha JK; Basha R
    Int J Dev Neurosci; 2015 Nov; 46():92-9. PubMed ID: 26287661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The synthetic retinoid RO 13-6307 induces neuroblastoma differentiation in vitro and inhibits neuroblastoma tumour growth in vivo.
    Ponthan F; Johnsen JI; Klevenvall L; Castro J; Kogner P
    Int J Cancer; 2003 Apr; 104(4):418-24. PubMed ID: 12584737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability and dose-dependent anti-tumour effects of 9-cis retinoic acid on human neuroblastoma xenografts in rat.
    Ponthan F; Kogner P; Bjellerup P; Klevenvall L; Hassan M
    Br J Cancer; 2001 Dec; 85(12):2004-9. PubMed ID: 11747346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness.
    Giannini G; Di Marcotullio L; Ristori E; Zani M; Crescenzi M; Scarpa S; Piaggio G; Vacca A; Peverali FA; Diana F; Screpanti I; Frati L; Gulino A
    Cancer Res; 1999 May; 59(10):2484-92. PubMed ID: 10344762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The deubiquitinating enzyme UCHL1 is a favorable prognostic marker in neuroblastoma as it promotes neuronal differentiation.
    Gu Y; Lv F; Xue M; Chen K; Cheng C; Ding X; Jin M; Xu G; Zhang Y; Wu Z; Zheng L; Wu Y
    J Exp Clin Cancer Res; 2018 Oct; 37(1):258. PubMed ID: 30359286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoids in pediatric onco-hematology: the model of acute promyelocytic leukemia and neuroblastoma.
    Masetti R; Biagi C; Zama D; Vendemini F; Martoni A; Morello W; Gasperini P; Pession A
    Adv Ther; 2012 Sep; 29(9):747-62. PubMed ID: 22941525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced differentiation affords neuroblastoma cells protection from hypoxic injury.
    Hoehner JC; Prabhakaran K
    J Pediatr Surg; 2003 Jul; 38(7):1069-74. PubMed ID: 12861542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a new derivative of retinoic acid on proliferation and differentiation in human neuroblastoma cells.
    Bartolini G; Orlandi M; Ammar K; Magrini E; Ferreri AM; Rocchi P
    Anticancer Res; 2003; 23(2B):1495-9. PubMed ID: 12820415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the Effects of 13-cis Retinoic Acid and Melatonin on the Viabilities of SH-SY5Y Neuroblastoma Cell Line.
    Tosun M; Soysal Y; Mas NG; Karabekir HS
    J Korean Neurosurg Soc; 2015 Mar; 57(3):147-51. PubMed ID: 25810852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-gamma cooperates with retinoic acid and phorbol ester to induce differentiation and growth inhibition of human neuroblastoma cells.
    Guzhova I; Hultquist A; Cetinkaya C; Nilsson K; Påhlman S; Larsson LG
    Int J Cancer; 2001 Oct; 94(1):97-108. PubMed ID: 11668484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of retinoic acid receptor alpha expression in human neuroblastoma cell lines and tumor tissue.
    Marshall GM; Cheung B; Stacey KP; Norris MD; Haber M
    Anticancer Res; 1994; 14(2A):437-41. PubMed ID: 8017844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. All-Trans-Retinoic Acid Stimulates Overexpression of Tumor Protein D52 (TPD52, Isoform 3) and Neuronal Differentiation of IMR-32 Cells.
    Kotapalli SS; Dasari C; Duscharla D; Kami Reddy KR; Kasula M; Ummanni R
    J Cell Biochem; 2017 Dec; 118(12):4358-4369. PubMed ID: 28436114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutically targeting oncogenic CRCs facilitates induced differentiation of NB by RA and the BET bromodomain inhibitor.
    Alleboina S; Aljouda N; Miller M; Freeman KW
    Mol Ther Oncolytics; 2021 Dec; 23():181-191. PubMed ID: 34729395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.